Role of epidermal growth factor receptor mutations in predicting sensitivity or resistance to targeted agents in non-small-cell lung cancer.
Reddy
G Kesava
GK
D019943:Amino Acid Substitution; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D044466:Asian People / Q000235:genetics; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics*; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D008715:Methionine / Q000235:genetics; D009154:Mutation; D011799:Quinazolines / Q000627:therapeutic use*; D012737:Sex Factors; D013912:Threonine / Q000235:genetics
D000970:Antineoplastic Agents; D011799:Quinazolines; D013912:Threonine; D008715:Methionine; D066246:ErbB Receptors; D000077156:Gefitinib